Hyris System News Today

Hyris molecular diagnostic technology has been adapted to enable real-time surveillance of mosquito vector insecticide resistance, which will aid...

Ulisse Biomed S.p.A. announces that its subsidiary Hyris Limited has entered into an agreement with the Defence and Certification Research Centre of the Council for Agricultural Research and...

Ulisse Biomed Spa announced Thursday that its subsidiary Hyris Limited has signed an agreement with the Defense and Certification Research Center of the Council for Agricultural Research and Analysis...

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell...

Investegate announcements from Hyris, Hyris New T-Cell Test is Finally Available to EU Countries to Easily Map Patients Cellular Immunity to SARS-CoV-2

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology

Investegate announcements from Hyris, A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of...

Investegate announcements from Hyris, Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference A-Wish

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new so...